What is the current stock price of CanBas Co., Ltd. (4575.T)?

As of the latest market data, CanBas Co., Ltd. (4575.T) is trading at $0.00. The stock has seen a loss of undefined% today.

Does CanBas Co., Ltd. (4575.T) pay a dividend?

Based on current data, CanBas Co., Ltd. does not have a confirmed active dividend policy.

What is the market cap of CanBas Co., Ltd.?

The current market capitalization of CanBas Co., Ltd. (4575.T) is approximately unavailable.

4575.T

CanBas Co., Ltd.·Healthcare

0.00

0.000%(+0.00)

Market Closed

Last Updated: — ET

52W L: $0.0052W H: $0.00

Company Profile

CanBas Co., Ltd., a clinical stage biopharmaceutical company, develops therapeutics for cancer patients. It develops CBP501, a calmodulin-modulating peptide to treat various cancer; and CBS9106, a reversible exportin-1inhibitor that is in Phase I clinical trial for the treatment of solid tumors. The company has a collaboration alliance with Stemline Therapeutics, Inc. CanBas Co., Ltd. was incorporated in 2000 and is based in Numazu, Japan.

Sector

Healthcare

Industry

Biotechnology

Employees

IPO Date

2009-09-17

Beta

-0.84

Websitewww.canbas.co.jp↗